Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms receiving pharmacologic therapy for benign prostatic ...

In a recent interview with CURE, Dr. Kai Tsao discussed treatment advancements for patients with prostate cancer. In a recent interview with CURE, Dr. Kai Tsao broke down current treatment ...

A Virginia startup calling itself “Operation Bluebird” announced this week that it has filed a formal petition with the US Patent and Trademark Office, asking the ...

Francis Medical is heating up with a 510(k) clearance from the FDA for its water vapor ablation therapy aimed at cancers of the prostate, kidneys and bladder. The regulatory go-ahead for its Vanquish ...

Israel isn’t the world’s most popular country, except when it comes to military hardware. A country the size of New Jersey is now the world’s eighth-largest arms exporter with a record-breaking $15 ...

Dec. 15, 2025 — For decades, when tests suggested that a man might have prostate cancer, the next step was usually a biopsy. The procedure, where a doctor uses a thin needle to collect prostate ...

Patients who received ADT for 3 months or 9 months had worse overall survival than those treated for 36 months. For men with prostate cancer treated with definitive radiotherapy, the benefit derived ...

Welcome to Derry’s second episode is full of more creepy nightmares and unsettling moments. Lilly and Ronnie are caught up in the crosshairs of the recent theater massacre, with both girls having to ...

Arrests, raids and protests have become daily occurrences as the presence of ICE in Chicago has drastically increased since the Department of Homeland Security launched what it dubbed "Operation ...